Quality & Safety
We continuously monitor the safety, efficacy and quality of our products to safeguard patients and support ongoing product improvement. Select a topic to connect with the right team.
Tel: +46 702 62 38 52
or E-mail: pv@ometpharma.com
Report a suspected side effect directly to the national medicines authority in your country. Each authority’s reporting service is available in the local language.
- Sweden — Läkemedelsverket
- Denmark — Lægemiddelstyrelsen
- Finland — Fimea
- Iceland — Icelandic Medicines Agency
- Norway — DMP (from 2027)
Alternatively: Tel: +46 702 62 38 52 or E-mail: pv@ometpharma.com
Tel: +46 702 62 38 52
or E-mail: info@ometpharma.com
Further information is available from the national medicines authorities:
Iceland — Icelandic Medicines Agency
We are constantly monitoring the safety and efficacy of our products for continual product quality improvement.
Up next
Contact Us
The three offices, the named Responsible Person, and the direct line for opening a partnership conversation.